טוען...
Evaluating the Long-term Efficacy of Coronavirus Disease 2019 (COVID-19) Vaccines
Large-scale deployment of safe and durably effective vaccines can curtail the coronavirus disease-2019 (COVID-19) pandemic. However, the high vaccine efficacy (VE) reported by ongoing phase 3 placebo-controlled clinical trials is based on a median follow-up time of only about 2 months, and thus does...
שמור ב:
| הוצא לאור ב: | Clin Infect Dis |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7989522/ https://ncbi.nlm.nih.gov/pubmed/33693529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciab226 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|